Genetics of Ehlers-Danlos Syndrome

Active, not recruitingOBSERVATIONAL

Enrollment

334

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Genetics SyndromeEhlers-Danlos Syndrome

Interventions

DIAGNOSTIC_TEST

Genotyping

Genotyping by next generation sequencing

Trial Locations (1)

Boston Medical Center, Boston

All Listed Sponsors

lead

Boston University

OTHER

NCT03093493 - Genetics of Ehlers-Danlos Syndrome | Biotech Hunter | Biotech Hunter